Skip directly to page options Skip directly to A-Z link

Volume 16, Number 1—January 2010

Letter

Skin Lesion Caused by ST398 and ST1 MRSA, Spain1

Carmen Aspiroz, Carmen Lozano, Ana Vindel, Juan J. Lasarte, Myriam Zarazaga, and Carmen TorresComments to Author 
Author affiliations: Hospital Royo Villanova, Zaragoza, Spain (C. Aspiroz); Universidad de La Rioja, Logroño, Spain (C. Lozano, M. Zarazaga, C. Torres); Centro Nacional Microbiología, Madrid, Spain (A. Vindel); Centro Salud San Mateo de Gállego, Zaragoza (J.J. Lasarte)

Main Article

Table

Characteristics of the 9 MRSA strains recovered in Spain from a patient’s lesion and from nasal samples obtained from patient’s family members*

Strain Origin of sample SCCmec type MLST spa type agr Antimicrobial resistance phenotype Resistance genes detected Amino acid change in:
GrlA GyrA
C1570 Patient/
skin lesion V ST398 t011 I OXA, FOX, TET, ERY, CLI, TEL mecA, tetK, ermA, ermC, msrA NP NP
C1569 Patient/
skin lesion II ST1 t127 III OXA, FOX, TET, ERY, CLI, TEL, GEN, TOB, KAN, CIP, LEV, SXT mecA, tetL, tetK, ermA, ermB, ermC, msrA, aph(2’)-acc(6’), ant(4´)-Ia, aph (3’), dfrK S80F S84L
C1571 Patient/
nasal swab V ST398 t108 I OXA, FOX, TET, ERY, CLI, TEL, CIP†, LEV† mecA, tetK, tetL, tetM, ermA, ermC, msrA Wild Wild
C1577 Mother/ nasal swab V ST398 t108 I OXA, FOX, TET, ERY, CLI, TEL, CIP†, LEV† mecA, tetK, tetM, ermA, ermC, msrA Wild Wild
C1578 Mother/
nasal swab II ST1 t127 III OXA, FOX, TET, ERY, CLI, TEL, GEN, TOB, KAN, CIP, LEV, SXT mecA, tetL, tetK, ermA, ermB, ermC, msrA, aph(2’)-acc(6’), ant(4´)-Ia, aph (3’), dfrK S80F S84L
C1574 Brother/
nasal swab V ST398 t011 I OXA, FOX, TET, ERY, CLI, TEL mecA, tetK, ermA, ermC, msrA NP NP
C1576 Brother/
nasal swab V ST398 t011 I OXA, FOX, TET, ERY, CLI, TEL, GEN, TOB, KAN, SXT mecA, tetL, tetK, ermA, ermB, ermC, msrA, aph(2’)-acc(6’), ant(4´)-Ia, aph (3’), dfrK NP NP
C1572 Father/
nasal swab V ST398 t108 I OXA, FOX, TET, ERY, CLI, TEL, CIP†, LEV† mecA, tetK, tetL, tetM, ermA, ermC, msrA Wild Wild

*MRSA, methicillin resistant Staphylococcus aureus; SCC, staphylococcal cassette chromosome; MLST, multilocus sequence typing; ST, sequence type; OXA, oxacillin; FOX, cefoxitin; TET, tetracycline; ERY, erythromycin; CLI, clindamycin; TEL, telithromycin; NP, not performed; GEN, gentamicin; TOB, tobramycin; KAN, kanamycin; CIP, ciprofloxacin; LEV, levofloxacin; SXT, sulfamethoxazole-trimethoprim.
†Iintermediate category for the indicated antimicrobial drug.

Main Article

1This study was presented as a poster at the 19th European Congress of Clinical Microbiology and Infectious Diseases, Helsinki, Finland, 2009.

Page created: March 31, 2011
Page updated: March 31, 2011
Page reviewed: March 31, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external